INTRODUCTION
Traditionally, the complement fixation test (CF) has been used for the identification (typing) and classification (subtyping) of isolates of foot and mouth disease virus (FMDV) (4, 5, 11, 16) . The reagents for such tests are prepared by a variety of methods in different laboratories around the world and there is a need for the development of standard procedures. In the case of antigens such methods would be for the preparation of reference sera and for use in subtyping. It would be advantageous if antigens were inactivated to permit safe handling within and transportation between laboratories and also if they were stable during long-term storage.
We have tested procedures for producing inactivated 146S antigens based on those proposed by Rowlands et al. (17) . The suitability of these for use with different types and subtypes of FMDV, their stability during long-term storage at different temperatures, and their activity as immunogens for gui nea pigs have been evaluated.
MATERIALS AND METHODS

Antigen production.
The following regimen was adopted for the production of inactivated 146S antigens :
1. Selected strains of the seven immunological types of FMDV (Table I) were grown in BHK-21 cells, the majority in monolayers and a few in suspen sion cultures, harvested when cultures showed maximal CPE and clarified by centrifugation.
2. The inactivation of infectivity was carried out by either of two proce dures : fa) a 1:10 volume of 0.5% formaldehyde in 0.04 M phosphate buffer (P0 4 buffer) was added (i.e. 0.05% v/v final concentration) and suspensions maintained at 20°C for 72 hours, followed by the addition of a 1:10 volume of acetylethyleneimine (AEI; 0.05% v/v final concentration) at either 26°C for 24 hours or 37°C for 6 hours (17) . The inactivation reactions were stop ped with excess sodium metabisulphite (solutions were immediately buffered with 8.8% sodium bicarbonate solution) and sodium thiosulphate, respecti vely, or (b) in the absence of the formaldehyde stage, AEI was added as pre viously described and virus cultures were maintained at 37 °C for an extended period of 24 hours (6).
Virus inactivation was verified by the method of Anderson et al. (1).
3. Concentration of virus and removal of lipid material was carried out using Polyethylene-glycol and trichloroethylene (TCE) (9) . The aqueous sus pensions resulting from TCE treatment were centrifuged at either 25,000 rpm for 3.5 hours or 30,000 rpm for 2 hours. Pellets were resuspended in P0 4 buffer or 0.05 M tris buffer containing 0.01 M sodium chloride, pH 7.6. Nonidet P-40 was added to a final concentration of 1 % and samples layered on to 15-45% linear sucrose gradients buffered with the corresponding buffer and centrifuged at 30,000 rpm for 3 hours. Samples of the gradient were run through a flow cell of a Unicam SP 1800 ultraviolet spectrophotometer using a similar method to that described by Barteling and Meloen (3). The antigens were quantified by the method of Bachrach et al. (2) , dispensed in glass con tainers treated with a water repellent (Repelcote)* and stored either at -70°C or above liquid nitrogen as concentrated sucrose gradient material or diluted with buffer to contain either 5 or 10 µg/ml.
Guinea pig anti-146S serum.
The minimum effective single dose of 146S antigen required to inoculate guinea pigs was investigated using virus strains O France 1/81 and Asia 1 Cambodia 9/80. Guinea pigs (400-500 gm) were inoculated subcutaneously with varying concentrations of 146S antigen in 1 ml of buffer with an equal volume of Freund's complete adjuvant. After 4 weeks, the guinea pigs were killed and exsanguinated, the serum separated and heat-inactivated at 56°C for 30 minutes. Antisera were raised against 146S antigens of other strains by using an inoculum containing 10 µg per animal.
Antigen stability.
To test the influence of formaldehyde treatment on the long-term stability of virus, pools of strains O BFS 1860 and C Resende antigens were prepared by both inactivation procedures, held at 4°C and tested spectrophotometrically at intervals for 146S content. Percentage losses were determined by comparison with control preparations of non-formaldehyde/AEI treated 146S antigens stored under the same conditions. Other antigens which had been stored at -70°C and above liquid nitrogen for long periods, were also retested for 146S concentration.
The immunogenicity of the materials stored at 4°C and of others from above liquid nitrogen was examined by determination of antibody responses of guinea pigs inoculated with 10 µg as previously described.
Complement fixation test.
The micro-complement fixation test (CF) technique was employed (8) . Reagents were added in the following volumes : fi) antiserum dilution, 25 µl; (ii) three 50% haemolytic doses of complement, 50 (A; (Hi) antigen (either tissue culture material or inactivated 146S at 1 µg/ml, 25 (A), and (iv) haemolytic indicator system, 25 ¡A. CF titres were expressed as the reciprocal of the serum dilution producing 75% haemolysis.
Micro-neutralisation test.
Serum neutralisation tests were carried out in microtitre plates using the method employed by Golding et al. (13) . Equal volumes of a dilution series of sera were mixed with 100 TCID 50 virus and incubated at 37°C with an IB-RS-2 cell suspension. Neutralisation titres were expressed as the reciprocal of the final dilution of serum that neutralised 50% virus.
RESULTS
FMDV antigen production.
All strains yielded working harvests in the infectivity range log 10 7.5-8.5 TCID 50 /ml; however, such levels were more difficult to obtain with SAT 1 Tanzania 155/71 and SAT 2 R1215.
The concentrations of 146S particles obtained after inactivation and purification expressed as a ratio to 10 8 cells, the average number of cells in a BHK Roux monolayer, are shown in Table I . There was marked variation in the quantities of inactivated 146S obtained both between and within types of FMDV. Thus, two Asia 1 strains, Cambo dia 9/80 and Pakistan 1/54, withstood formaldehyde pretreatment, judging by the high amounts of 146S antigen obtained, strain India 8/79 less well and strain Turkey 1973 not at all. Additionally, Turkey 1973 failed to withstand AEI inactivation alone. Although not all strains were inactivated by both regimens, direct comparisons can be made with some. O Lausanne and A Cruzeiro yielded similar levels of 146S by either procedure and C Noville pro duced slightly lower amounts by formaldehyde plus AEI treatment than by AEI inactivation alone (46.5% and 68.9% of live 146S particle recovery res pectively). In many cases inactivation by a combination of formaldehyde plus AEI significantly reduced the level of 146S particles that were recovered. 
Guinea pig anti-146S serum.
The range and mean of the antiserum titres of guinea pigs inoculated with a single dose of 10 µg of antigen are listed in Table I . There was a wide varia tion in individual guinea pig antiserum titres although the majority of the strains generally stimulated a mean antiserum titre of >100. The prepara tions of O India 1/62, A Cruzeiro and SAT 2 SAR 3/79 stimulated lower res ponses than others and it proved necessary to repeat the procedure with SAT 1 Tanzania 155/71 as the first antigen stimulated a response in only 20% of inoculated animals. The results in Table II illustrate that guinea pigs showed similar neutralising antibody responses with doses of 0.64 µg or more. Several individuals produced antiserum with detectable neutralising antibody at doses as low as 0.04 µg. There was no marked variation in antise rum CF titre when doses were reduced to 0.64 µg for O France 1/81, but CF titres were successively lower at each reduced dose of Asia 1 Cambodia 9/80.
Antigen stability.
Pools of O BFS 1860 antigens prepared by both inactivation procedures maintained the same 146S concentrations over the examination period of 19 weeks at 4°C. In contrast, C Resende 146S inactivated by formaldehyde plus AEI was reduced by 15% after 9 weeks. When inactivated by AEI alone, however, there was no reduction. AEI inactivated antigens stored at -70°C lost from 6.5% to 28% of 146S particles over a period of 9 months (Table III) , whereas antigens stored above liquid nitrogen showed either no or very little breakdown over periods up to 59 weeks.
The antibody responses of guinea pigs inoculated with antigens before and after storage are shown in Table IV . The results obtained with C Resende indicate that formaldehyde had reduced the quality of the antigen as both neutralisation and CF titres were depressed and a higher dose of formaldehyde-fixed material was required to provoke an adequate response (results not shown). However, the antigen appeared to maintain this same level of immunogenicity upon storage at 4°C while that prepared from AEI treatment alone induced a slightly lower neutralising antibody response than previously obtained. Guinea pigs inoculated with preparations of O BFS 1860 antigens stored at 4°C for 19 weeks produced antisera of similar neutralising and CF titre to those obtained with other freshly prepared O BFS 1860 anti gens. Each of the strains retested from liquid nitrogen maintained immuno genicity upon storage.
DISCUSSION
Current methods for preparing reagents for CF tests for FMD diagnosis and subtyping vary at different laboratories and some can be criticised on the grounds of being less than optimal. For example, hyperimmune guinea pig sera is often used in both tests and the necessity of adapting FMDV strains to guinea pigs exerts a species-selective pressure which could result in sera of misleading reactivity. Furthermore, the use of crude concentrated tissue cul ture harvests of virus in subtyping can reduce the specificity of CF reactions through the presence of 75S and 12S subunits (18, 7) .
To eliminate some of these disadvantages it was considered that it might be of value to examine the suitability of inactivated 146S preparations of FMDV as immunogens for producing antiserum for typing and subtyping tests and as known positive controls for typing reactions. As a first step, pro cedures for producing inactivated 146S antigens were evaluated and a method involving combined formaldehyde and AEI treatment was compared with AEI treatment alone. Pretreatment with formaldehyde has been shown to prevent disruption by AEI (17) and to improve vaccine potency (15) . It was considered that formaldehyde might, therefore, have a stabilising influence on other FMDV strains and protect against proteolytic degradation that has been shown to occur during storage of concentrated antigens (10).
While formaldehyde improved the stabilisation of SAT 2 Kenya 183/74 146S antigen, it had either little influence on the 146S recovery rates of some strains (e.g. O Lausanne), produced reduction of others (e.g. O BFS 1860, C Resende) or degraded others (e.g. A France 1/68). In several cases pretreat- ment with formaldehyde resulted in antigens of reduced immunogenicity for guinea pigs. This was not surprising as it is recognised that both the quality and mass of an antigen are important in influencing immunogenic potency (15, 9, 10) .
The long-term storage stability of a range of 146S antigens at different temperatures was assessed both in terms of quantity by direct spectrophotometric measurement and of quality by guinea pig immunogenic response. The latter was taken as an indirect indication of the preservation of antigenic integrity. Investigations by Doel and Collen (10) of the practicality of storing FMD vaccines as concentrated preparations have highlighted the importance of preserving the antigenic polypeptide VP1 against proteolytic degradation.
It was found that only C Resende antigen prepared by combined formaldehyde and AEI treatment degraded at 4°C, judged by lower spectrophotometric readings and depressed antiserum titres. There was a variation in 146S degradation of strains stored at -70°C, whilst those maintained above liquid nitrogen for long periods showed very little deterioration and their immunogenic properties were not greatly altered.
The minimum amount of antigen necessary to produce sera with workable antibody titres was found to be 0.64 µg, in agreement with Morgan et al. (14) and Forman (12) . The specificity and performance of the guinea pig anti-146S sera in serological tests will be presented in a subsequent paper.
The choice of inactivation procedure, therefore, presents a problem in that while formaldehyde pretreatment may reduce 146S concentration prior to AEI inactivation and affect antigenic sites, the residual antigen is likely to maintain immunogenicity for longer at 4°C than without it. Its use, however, might be limited to strains which are susceptible to degradation during inactivation. An investigation to find alternative procedures for improving the antigen stability of labile strains would be worth pursuing. 
